BCAX Sale Disclosure
Cohlhepp Ryan · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$80.66K
Cohlhepp Ryan President, COO & Interim CEO
BCAX
Transaction date
Sep 8, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 2 days later
BCAX daily price context
Close on/before transaction
$23.71
Sep 8, 2026
Close before public filing
$23.64
Sep 9, 2026
Return since public filing
-1.86%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,442 shares @ $23.43
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000883
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$467.04K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bicara Therapeutics Inc. BCAX | Exercise | Sep 8, 2026 | $66.32K |
| Bicara Therapeutics Inc. BCAX | Sale | Sep 8, 2026 | $320.05K |
| Bicara Therapeutics Inc. BCAX Current | Sale | Sep 8, 2026 | $80.66K |
| Bicara Therapeutics Inc. BCAX | Exercise | Sep 8, 2026 | $0 |